other material
confidence high
sentiment neutral
materiality 0.55
Provectus seeks approval for 1-for-10 to 1-for-50 reverse stock split at June 22 annual meeting
PROVECTUS BIOPHARMACEUTICALS, INC.
- Filed preliminary proxy; meeting scheduled for June 22, 2022; record date April 25, 2022.
- Reverse split ratio range is 1-for-10 to 1-for-50, applies to common stock and Series D/D-1 preferred.
- Authorized share reduction proposal contingent on reverse split approval; both require stockholder approval.
- Stockholders also vote on director election, executive compensation, and auditor ratification.